Implications of pharmacogenomics for drug development and clinical practice.

@article{Ginsburg2005ImplicationsOP,
  title={Implications of pharmacogenomics for drug development and clinical practice.},
  author={Geoffrey S. Ginsburg and Richard P. Konstance and Jennifer S Allsbrook and Kevin A. Schulman},
  journal={Archives of internal medicine},
  year={2005},
  volume={165 20},
  pages={2331-6}
}
Pharmacogenomics is likely to be among the first clinical applications of the Human Genome Project and is certain to have an enormous impact on the clinical practice of medicine. Herein, we discuss the potential implications of pharmacogenomics on the drug development process, including drug safety, productivity, market segmentation, market expansion, differentiation, and personalized health care. We also review 3 challenges facing the translation of pharmacogenomics into clinical practice… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
19 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 19 extracted citations

Similar Papers

Loading similar papers…